Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Identification of a universal Group B streptococcus vaccine by multiple genome screen.

Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, Scarselli M, Tettelin H, Brettoni C, Iacobini ET, Rosini R, D'Agostino N, Miorin L, Buccato S, Mariani M, Galli G, Nogarotto R, Nardi-Dei V, Vegni F, Fraser C, Mancuso G, Teti G, Madoff LC, Paoletti LC, Rappuoli R, Kasper DL, Telford JL, Grandi G.

Science. 2005 Jul 1;309(5731):148-50. Erratum in: Science. 2013 Jan 11;339(6116):141. Nardi Dei, Vincenzo [corrected to Nardi-Dei, Vincenzo].

2.

Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.

Yang HH, Mascuch SJ, Madoff LC, Paoletti LC.

Clin Vaccine Immunol. 2008 Jul;15(7):1035-41. doi: 10.1128/CVI.00030-08. Epub 2008 May 7.

4.

Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Seepersaud R, Hanniffy SB, Mayne P, Sizer P, Le Page R, Wells JM.

Infect Immun. 2005 Mar;73(3):1671-83.

5.
6.

Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.

Nilo A, Morelli L, Passalacqua I, Brogioni B, Allan M, Carboni F, Pezzicoli A, Zerbini F, Maione D, Fabbrini M, Romano MR, Hu QY, Margarit I, Berti F, Adamo R.

ACS Chem Biol. 2015 Jul 17;10(7):1737-46. doi: 10.1021/acschembio.5b00247. Epub 2015 May 6.

PMID:
25906283
8.

Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.

Erdogan S, Fagan PK, Talay SR, Rohde M, Ferrieri P, Flores AE, Guzmán CA, Walker MJ, Chhatwal GS.

Infect Immun. 2002 Feb;70(2):803-11.

9.

Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.

Martin D, Rioux S, Gagnon E, Boyer M, Hamel J, Charland N, Brodeur BR.

Infect Immun. 2002 Sep;70(9):4897-901.

10.

[Recombinant fragments of conservative proteins of group B streptococci as a basis of specific vaccine].

Suvorov AN, Grabovskaia KB, Leont'eva GF, Meringova LF, Koroleva IN, Duplik NV, Totolian AA.

Zh Mikrobiol Epidemiol Immunobiol. 2010 Mar-Apr;(2):44-50. Russian.

PMID:
20465000
11.
12.

Nonimmunodominant regions are effective as building blocks in a streptococcal fusion protein vaccine.

Stålhammar-Carlemalm M, Waldemarsson J, Johnsson E, Areschoug T, Lindahl G.

Cell Host Microbe. 2007 Dec 13;2(6):427-34.

13.

BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus.

Santi I, Maione D, Galeotti CL, Grandi G, Telford JL, Soriani M.

J Infect Dis. 2009 Aug 15;200(4):564-70. doi: 10.1086/603540.

14.

Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.

Larsson C, Stålhammar-Carlemalm M, Lindahl G.

Vaccine. 1999 Feb 5;17(5):454-8.

PMID:
10073723
15.

Vaccination with highly purified cell surface proteins confers protection against experimental group B streptococcal infection.

Larsson C, Stålhammar-Carlemalm M, Lindahl G.

Adv Exp Med Biol. 1997;418:851-3. No abstract available.

PMID:
9331786
16.

[Protective properties of certain external proteins of group B streptococci].

Grabovskaia KB, Leont'eva GF, Meringova LF, Vorob'eva EI, Suvorov AN, Totolian A.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Sep-Oct;(5):44-50. Russian.

PMID:
18038546
17.

Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial.

Kotloff KL, Corretti M, Palmer K, Campbell JD, Reddish MA, Hu MC, Wasserman SS, Dale JB.

JAMA. 2004 Aug 11;292(6):709-15.

PMID:
15304468
18.

Immunogenicity and physico-chemical characterisation of a candidate conjugate vaccine against group B streptococcus serotypes Ia, Ib and III.

Lancaster L, Saydam M, Markey K, Ho MM, Mawas F.

Vaccine. 2011 Apr 12;29(17):3213-21. doi: 10.1016/j.vaccine.2011.02.039. Epub 2011 Feb 26.

PMID:
21356338
19.

Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment.

Madureira P, Andrade EB, Gama B, Oliveira L, Moreira S, Ribeiro A, Correia-Neves M, Trieu-Cuot P, Vilanova M, Ferreira P.

PLoS Pathog. 2011 Nov;7(11):e1002363. doi: 10.1371/journal.ppat.1002363. Epub 2011 Nov 17.

20.

Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.

Brodeur BR, Boyer M, Charlebois I, Hamel J, Couture F, Rioux CR, Martin D.

Infect Immun. 2000 Oct;68(10):5610-8.

Items per page

Supplemental Content

Write to the Help Desk